article thumbnail

Bristol Myers Squibb Awards “Golden Tickets” to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabsf

The Pharma Data

Bristol Myers Squibb has annually held the Golden Ticket contest since it began in Cambridge in 2016 for promising biotech launch-ups pursuing exploration in new target identification, medicine delivery, discovery technology platforms or translational R&D in a variety of remedial exploration fields.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. Bioinformatics is all about bringing together different areas of knowledge.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.

article thumbnail

SRP-001: redefining pain treatment with a safer, non-opioid analgesic

Drug Target Review

was founded in 2016 to develop safer, non-opioid therapies for acute and chronic pain. Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. South Rampart Pharma, Inc.

article thumbnail

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

The Pharma Data

The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of Molecular Biology. 2016), 59, 6595-6628. References. Hilgenfeld, Febs J. 2014), 281, 4085-4096. Pillaiyar, et al, J.

article thumbnail

Alzheimer’s disease: driving advancements with precision medicine

Drug Target Review

2016, August 2). Progress in molecular biology and translational science. Blennow, K., Carrillo, M. Feldman, H. Frisoni, G. Jagust, W. Johnson, K. Knopman, D. Petersen, R. Scheltens, P., Sperling, R. A., & Dubois, B. A/t/N: An unbiased descriptive classification scheme for alzheimer disease biomarkers. link] Cousins, K.

Disease 59
article thumbnail

Low oxygen levels restore balance and coordination in a mouse model of a movement disorder

Broad Institute

said Vamsi Mootha , senior author of the study, an institute member at the Broad, professor of systems biology and medicine at Harvard Medical School, and professor of molecular biology at Massachusetts General Hospital. Mootha’s lab has been studying hypoxia as a potential treatment for rare neurological diseases since 2016.